Key result
A patient receiving mirtazapine and risperidone developed severe and life-threatening rhabdomyolysis and pulmonary thromboembolism.
Case Report (n=1)
The combination of mirtazapine and risperidone may be associated with severe adverse events including rhabdomyolysis and pulmonary thromboembolism.
May warrant vigilance for rhabdomyolysis and thromboembolism with mirtazapine-risperidone; leaves open causality pending systematic study.
Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.Sir: Mirtazapine may be combined with antipsychotic drugs to treat depressive disorders complicated by psychosis.1 Mirtazapine is an effective and safe drug in this setting.2 We describe severe and life-threatening rhabdomyolysis and pulmonary thromboembolism in a patient receiving mirtazapine and risperidone.†‹†‹
No takes yet. Share an insight, caveat, or question.
Zink et al. (2006) conducted a case report in Depressive disorders complicated by psychosis (n=1). Mirtazapine and risperidone was evaluated on Severe and life-threatening rhabdomyolysis and pulmonary thromboembolism. A patient receiving mirtazapine and risperidone developed severe and life-threatening rhabdomyolysis and pulmonary thromboembolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: